Risk prediction model for in-stent restenosis following PCI: a systematic review
- PMID: 39267809
- PMCID: PMC11390508
- DOI: 10.3389/fcvm.2024.1445076
Risk prediction model for in-stent restenosis following PCI: a systematic review
Abstract
Introduction: The morbidity and mortality rates of coronary heart disease are significant, with PCI being the primary treatment. The high incidence of ISR following PCI poses a challenge to its effectiveness. Currently, there are numerous studies on ISR risk prediction models after PCI, but the quality varies and there is still a lack of systematic evaluation and analysis.
Methods: To systematically retrieve and evaluate the risk prediction models for ISR after PCI. A comprehensive search was conducted across 9 databases from inception to March 1, 2024. The screening of literature and extraction of data were independently carried out by two investigators, utilizing the checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS). Additionally, the risk of bias and applicability were evaluated using the Prediction Model Risk of Bias Assessment Tool (PROBAST).
Results: A total of 17 studies with 29 models were included, with a sample size of 175-10,004 cases, and the incidence of outcome events was 5.79%-58.86%. The area under the receiver operating characteristic curve was 0.530-0.953. The top 5 predictors with high frequency were diabetes, number of diseased vessels, age, LDL-C and stent diameter. Bias risk assessment into the research of the risk of higher bias the applicability of the four study better.
Discussion: The overall risk of bias in the current ISR risk prediction model post-PCI is deemed high. Moving forward, it is imperative to enhance study design and specify the reporting process, optimize and validate the model, and enhance its performance.
Keywords: PCI; coronary heart disease; prediction model; restenosis; systematic review.
© 2024 Xiang, Xiong, Liu, Zhang, Li, Wang, Wu and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Risk factors of in-stent restenosis in patients with diabetes mellitus after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.Medicine (Baltimore). 2021 Apr 16;100(15):e25484. doi: 10.1097/MD.0000000000025484. Medicine (Baltimore). 2021. PMID: 33847656 Free PMC article.
-
Risk-Prediction Model of Restenosis after Endovascular Treatment for Peripheral Arterial Disease: A Systematic Review and Meta-analysis.J Endovasc Ther. 2024 Nov 8:15266028241289083. doi: 10.1177/15266028241289083. Online ahead of print. J Endovasc Ther. 2024. PMID: 39513458 Review.
-
Critical appraisal and assessment of bias among studies evaluating risk prediction models for in-hospital and 30-day mortality after percutaneous coronary intervention: a systematic review.BMJ Open. 2024 Jul 1;14(6):e085930. doi: 10.1136/bmjopen-2024-085930. BMJ Open. 2024. PMID: 38951013 Free PMC article.
-
Prediction models for amputation after diabetic foot: systematic review and critical appraisal.Diabetol Metab Syndr. 2024 Jun 10;16(1):126. doi: 10.1186/s13098-024-01360-6. Diabetol Metab Syndr. 2024. PMID: 38858732 Free PMC article. Review.
-
Risk prediction models for disability in older adults: a systematic review and critical appraisal.BMC Geriatr. 2024 Oct 2;24(1):806. doi: 10.1186/s12877-024-05409-z. BMC Geriatr. 2024. PMID: 39358747 Free PMC article.
References
-
- Zhang Q, Li T, Chen R, Zeng Z-H. Research progress of SGLT2i in the prevention of in-stent restenosis after percutaneous coronary intervention. J Pract Med. (2024) 40(08):1175–80. 10.3969/j.issn.1006-5725.2024.08.027 - DOI
-
- Yang S-M, Li S-C, Geng C-Q, Gao F. Research progress of in-stent restenosis after percutaneous coronary intervention. Combine Trad Chin West Med Jo Cardio Cerebrovasc Dis. (2023) 21(20):3754–60. 10.12102/j.issn.1672-1349.2023.20.013 - DOI
-
- Wang F, Li C, Ding F-H, Shen Y, Gao J, Liu Z-H, et al. Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells. Atherosclerosis. (2017):26710–18. 10.1016/j.atherosclerosis.2017.10.015 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous